ZA984432B - Use of low-molecular-weight heparins for the prevention and treatment of trauma of the central nervous system - Google Patents

Use of low-molecular-weight heparins for the prevention and treatment of trauma of the central nervous system

Info

Publication number
ZA984432B
ZA984432B ZA984432A ZA984432A ZA984432B ZA 984432 B ZA984432 B ZA 984432B ZA 984432 A ZA984432 A ZA 984432A ZA 984432 A ZA984432 A ZA 984432A ZA 984432 B ZA984432 B ZA 984432B
Authority
ZA
South Africa
Prior art keywords
trauma
prevention
molecular
treatment
low
Prior art date
Application number
ZA984432A
Other languages
English (en)
Inventor
Jean-Marie Stutzmann
Andre Uzan
Florence Wahl
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA984432B publication Critical patent/ZA984432B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA984432A 1997-05-28 1998-05-25 Use of low-molecular-weight heparins for the prevention and treatment of trauma of the central nervous system ZA984432B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9706550A FR2763848B1 (fr) 1997-05-28 1997-05-28 Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central

Publications (1)

Publication Number Publication Date
ZA984432B true ZA984432B (en) 1998-12-02

Family

ID=9507335

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA984432A ZA984432B (en) 1997-05-28 1998-05-25 Use of low-molecular-weight heparins for the prevention and treatment of trauma of the central nervous system

Country Status (24)

Country Link
US (1) US6380173B1 (zh)
EP (2) EP1421943A1 (zh)
JP (1) JP2002500660A (zh)
KR (1) KR100531721B1 (zh)
CN (1) CN1212845C (zh)
AR (1) AR012876A1 (zh)
AT (1) ATE276752T1 (zh)
AU (1) AU752322B2 (zh)
BR (1) BR9809504A (zh)
CA (1) CA2290675A1 (zh)
DE (1) DE69826460T2 (zh)
ES (1) ES2227841T3 (zh)
FR (1) FR2763848B1 (zh)
IL (2) IL132671A0 (zh)
MA (1) MA24553A1 (zh)
NO (1) NO317517B1 (zh)
NZ (1) NZ501365A (zh)
PE (1) PE74699A1 (zh)
PT (1) PT984786E (zh)
RU (1) RU2215531C2 (zh)
TN (1) TNSN98071A1 (zh)
TW (1) TW533075B (zh)
WO (1) WO1998053833A1 (zh)
ZA (1) ZA984432B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010041686A1 (en) * 2000-01-06 2001-11-15 Veronique Mary Novel therapeutic application of enoxaparin
ITMI20012599A1 (it) * 2001-12-11 2003-06-11 Cosmo Spa Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int
US9308220B2 (en) 2001-12-11 2016-04-12 Cosmo Technologies Limited Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
US7511026B2 (en) 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA829463B (en) * 1982-07-19 1983-10-26 Hepar Ind Inc Process for manufacturing low molecular weight heparins by depolymerization of normal heparin
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
IT1264530B (it) * 1992-07-31 1996-10-02 Crinos Industria Farmaco Impiego dei polisaccaridi nelle neuropatie atrofico degenerative

Also Published As

Publication number Publication date
BR9809504A (pt) 2000-06-20
MA24553A1 (fr) 1998-12-31
KR100531721B1 (ko) 2005-11-28
EP1421943A1 (fr) 2004-05-26
NO317517B1 (no) 2004-11-08
EP0984786A1 (fr) 2000-03-15
CN1212845C (zh) 2005-08-03
FR2763848B1 (fr) 2000-01-28
KR20010012988A (ko) 2001-02-26
DE69826460T2 (de) 2005-10-13
IL132671A0 (en) 2001-03-19
JP2002500660A (ja) 2002-01-08
CN1257428A (zh) 2000-06-21
EP0984786B1 (fr) 2004-09-22
TW533075B (en) 2003-05-21
NZ501365A (en) 2002-12-20
WO1998053833A1 (fr) 1998-12-03
AU7775998A (en) 1998-12-30
NO995538D0 (no) 1999-11-12
TNSN98071A1 (fr) 2005-03-15
NO995538L (no) 1999-11-12
ES2227841T3 (es) 2005-04-01
RU2215531C2 (ru) 2003-11-10
PE74699A1 (es) 1999-10-21
DE69826460D1 (de) 2004-10-28
AR012876A1 (es) 2000-11-22
ATE276752T1 (de) 2004-10-15
IL132671A (en) 2007-06-17
PT984786E (pt) 2005-01-31
FR2763848A1 (fr) 1998-12-04
US6380173B1 (en) 2002-04-30
AU752322B2 (en) 2002-09-19
CA2290675A1 (fr) 1998-12-03

Similar Documents

Publication Publication Date Title
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
AU5750796A (en) System for the treatment of insomnia
HUP0003591A3 (en) Treatment of oppositional deflant disorder
GB9519033D0 (en) Treatment
AU2058697A (en) Treatment of sleep disorders
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
ZA962714B (en) Effluent treatment system
EP0828503A4 (en) TREATMENT TO INHIBIT PROGRESS OF AUTOIMMUNE DISEASES
HK1022267A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
HUP9700661A3 (en) Use of alpha-1-adrenoreceptor antagonists for the production of pharmaceuticals for profilacting and treating cancer
ZA984432B (en) Use of low-molecular-weight heparins for the prevention and treatment of trauma of the central nervous system
GB9615159D0 (en) Treatment of liquid
EP0733365A3 (en) Use of benzoquinolin-3-one for the treatment and prevention of prostate cancer
PL331283A1 (en) Preparation for treating and/or preventing stupefaction
AU2002300292A1 (en) Use of low-molecular-weight heparins for preventing and treating central nervous system trauma
EP0880468A4 (en) TREATMENT OF BAUXITE
GB9619125D0 (en) Treatment of functional disorders of the pilosebaceous system
EG24149A (en) Drug fpr treatment of bilharziasis
ZA968923B (en) The treatment of sewage
GB9510961D0 (en) Hemorrhoid treatment and prevention
GB9622609D0 (en) Treatment of paralysis or muscle disorder
GB9623548D0 (en) The treatment of cold sores
ZA971471B (en) Process for the preparation of 2-halomethyl-penems and their use for the preparation of antibacterial penems.
GB9518241D0 (en) Treatment system
GB9602404D0 (en) Methods of treatment